Entrada Therapeutics Stock Price on March 22, 2024

TRDA Stock  USD 19.96  0.21  1.04%   
If you're considering investing in Entrada Stock, it is important to understand the factors that can impact its price. As of today, the current price of Entrada Therapeutics stands at 19.96, as last reported on the 4th of December, with the highest price reaching 20.26 and the lowest price hitting 19.60 during the day. Entrada Therapeutics appears to be not too volatile, given 3 months investment horizon. Entrada Therapeutics secures Sharpe Ratio (or Efficiency) of 0.16, which denotes the company had a 0.16% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Entrada Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Entrada Therapeutics' Mean Deviation of 2.26, downside deviation of 3.13, and Coefficient Of Variation of 1280.58 to check if our risk estimates are consistent with your expectations.
  
At present, Entrada Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 13.8 M, whereas Total Stockholder Equity is forecasted to decline to about 153.3 M. . At present, Entrada Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.84, whereas Price To Sales Ratio is forecasted to decline to 3.10. Entrada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1627

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsTRDA
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.84
  actual daily
25
75% of assets are more volatile

Expected Return

 0.46
  actual daily
9
91% of assets have higher returns

Risk-Adjusted Return

 0.16
  actual daily
12
88% of assets perform better
Based on monthly moving average Entrada Therapeutics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entrada Therapeutics by adding it to a well-diversified portfolio.
Price Book
1.7866
Enterprise Value Ebitda
5.9826
Price Sales
3.5067
Shares Float
18.4 M
Wall Street Target Price
25.57

Entrada Therapeutics Main Headline on 22nd of March 2024

Filed transaction by Entrada Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Entrada Therapeutics Valuation on March 22, 2024

It is possible to determine the worth of Entrada Therapeutics on a given historical date. On March 22, 2024 Entrada was worth 13.92 at the beginning of the trading date compared to the closed value of 13.72. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Entrada Therapeutics stock. Still, in general, we apply an absolute valuation method to find Entrada Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entrada Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Entrada Therapeutics' related companies.
 Open High Low Close Volume
  13.50    13.80    13.11    13.54    71,898  
03/22/2024
  13.92    13.96    13.34    13.72    64,728  
  13.86    13.99    13.12    13.38    38,641  
Backtest Entrada Therapeutics  |  Entrada Therapeutics History  |  Entrada Therapeutics Valuation   PreviousNext  
Open Value
13.92
13.72
Closing Value
22.45
Upside

Entrada Therapeutics Trading Date Momentum on March 22, 2024

On March 25 2024 Entrada Therapeutics was traded for  13.38  at the closing time. The top price for the day was 13.99  and the lowest listed price was  13.12 . The trading volume for the day was 38.6 K. The trading history from March 25, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 2.48% . The overall trading delta against the current closing price is 4.81% .

Entrada Therapeutics Fundamentals Correlations and Trends

By evaluating Entrada Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Entrada Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Entrada financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Entrada Therapeutics Stock history

Entrada Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entrada is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entrada Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entrada Therapeutics stock prices may prove useful in developing a viable investing in Entrada Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding33.1 M34.8 M
Net Loss-85.2 M-80.9 M

Entrada Therapeutics Quarterly Net Working Capital

403.73 Million

Entrada Therapeutics Stock Technical Analysis

Entrada Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Entrada Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Entrada Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Entrada Therapeutics Period Price Range

Low
December 4, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Entrada Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Entrada Therapeutics December 4, 2024 Market Strength

Market strength indicators help investors to evaluate how Entrada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entrada Therapeutics shares will generate the highest return on investment. By undertsting and applying Entrada Therapeutics stock market strength indicators, traders can identify Entrada Therapeutics entry and exit signals to maximize returns

Entrada Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Entrada Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Entrada Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Entrada to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Entrada Stock analysis

When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.